Using Blinatumomab in Acute Lymphoblastic Leukemia
0 Visninger
• 06/15/23
0
0
Indlejre
administrator
Abonnenter
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer